Drug intelligence / Profile preview

benzathine penicillin G

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intramuscular, Intravenous
01

Overview

Benzathine penicillin G is a long-acting, injectable antibiotic in the natural penicillins class. It is used to treat and prevent a variety of bacterial infections caused by susceptible organisms, including mild-to-moderate upper respiratory tract infections, syphilis, yaws, bejel, pinta, and to prevent rheumatic fever and related conditions. The drug consists of the combination of benzathine (which slows absorption) with penicillin G (benzylpenicillin), resulting in prolonged low serum levels after intramuscular injection. Its mechanism of action involves inhibiting bacterial cell wall synthesis by binding to and inactivating transpeptidase enzymes involved in peptidoglycan cross-linking during cell wall biosynthesis. This leads to osmotic instability and lysis of susceptible bacteria[1][2][7][8]. It is not effective against viral infections or for use in patients with known hypersensitivity to penicillins.

Brand names
Bicillin L-AExtencillinePermapen
Other names
Benzathine benzylpenicillinBenzylpenicillin benzathineDibenzylethylenediamine benzylpenicillin
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on benzathine penicillin G.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benzathine penicillin G.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call